Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

(2014) Shyam Sundar et al.   PLoS Neglected Tropical Diseases

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

(2014) Sakib Burza et al.   PLoS Neglected Tropical Diseases

How Far Are We from Visceral Leishmaniasis Elimination in Bangladesh? An Assessment of Epidemiological Surveillance Data

(2014) Rajib Chowdhury et al.   PLoS Neglected Tropical Diseases

Epidemiology of visceral leishmaniasis

(2014) Paul Ready   Clinical Epidemiology

Leishmania donovani: Dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis

(2013) Vikash Kumar et al.   NUTRITION

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study

(2013) Dinesh Mondal et al.   Lancet Global Health

A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis

(2012) Jane Cunningham et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

(2012) S. Sundar et al.   CLINICAL INFECTIOUS DISEASES

Liposomal amphotericin B as a treatment for human leishmaniasis

(2012) Manica Balasegaram et al.   EXPERT OPINION ON EMERGING DRUGS

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

(2011) Shyam Sundar et al.   LANCET

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

(2010) Prabhat K. Sinha et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends

(2010) Stanislaw Gorski et al.   PLoS Neglected Tropical Diseases

Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

(2008) T. P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY